
The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden.
Debashis Sahoo is Executive Vice-President, Regulators & Key Customers, MedInstill Development.

The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden.

Published: February 2nd 2018 | Updated: